UA105323U - Method for treating mixed nematode-cestode invasion in chickens - Google Patents

Method for treating mixed nematode-cestode invasion in chickens

Info

Publication number
UA105323U
UA105323U UAU201509726U UAU201509726U UA105323U UA 105323 U UA105323 U UA 105323U UA U201509726 U UAU201509726 U UA U201509726U UA U201509726 U UAU201509726 U UA U201509726U UA 105323 U UA105323 U UA 105323U
Authority
UA
Ukraine
Prior art keywords
chickens
invasion
cestode
body weight
treating mixed
Prior art date
Application number
UAU201509726U
Other languages
Ukrainian (uk)
Inventor
Тетяна Вікторівна Маршалкіна
Original Assignee
Державна Установа Інститут Сільського Господарства Степової Зони Національної Академії Аграрних Наук України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державна Установа Інститут Сільського Господарства Степової Зони Національної Академії Аграрних Наук України filed Critical Державна Установа Інститут Сільського Господарства Степової Зони Національної Академії Аграрних Наук України
Priority to UAU201509726U priority Critical patent/UA105323U/en
Publication of UA105323U publication Critical patent/UA105323U/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Спосіб лікування курей, хворих на змішану нематодозно-цестодозну інвазію, включає призначення фенбендазолу. Додатково застосовують левамізол і ретинолу ацетат, в наступній послідовності: на першу добу дають левамізол 20-30 мг діючої речовини на кг маси тіла одноразово, на третю добу - фенбендазол 10-15 мг діючої речовини на кг маси тіла одноразово, потім - ретинолу ацетат 25-50 тис. міжнародних одиниць на кг маси тіла.A method of treating chickens with mixed nematode-cestodal invasion involves the administration of fenbendazole. Levamisole and retinol acetate are additionally used, in the following sequence: on the first day, levamisole is given 20-30 mg of active substance per kg of body weight once, on the third day - fenbendazole 10-15 mg of active substance is on kg of body weight once, then - 25% of retinol acetate -50 thousand international units per kg of body weight.

UAU201509726U 2015-10-07 2015-10-07 Method for treating mixed nematode-cestode invasion in chickens UA105323U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201509726U UA105323U (en) 2015-10-07 2015-10-07 Method for treating mixed nematode-cestode invasion in chickens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201509726U UA105323U (en) 2015-10-07 2015-10-07 Method for treating mixed nematode-cestode invasion in chickens

Publications (1)

Publication Number Publication Date
UA105323U true UA105323U (en) 2016-03-10

Family

ID=55699141

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201509726U UA105323U (en) 2015-10-07 2015-10-07 Method for treating mixed nematode-cestode invasion in chickens

Country Status (1)

Country Link
UA (1) UA105323U (en)

Similar Documents

Publication Publication Date Title
MX2022004374A (en) Treatment of cancer using tlr9 agonist with checkpoint inhibitors.
NZ742208A (en) Topical pharmaceutical formulations for treating inflammatory-related conditions
MX2023000320A (en) Methods of modulating drug plasma levels using erythrohydroxybupropion.
CA2956871C (en) Compounds active towards bromodomains
MX2018008190A (en) Systems and methods for long term transdermal administration.
CL2017002904A1 (en) Methods and kits to treat depression
AR108021A1 (en) ADJUSTMENTS OF ANTIBODY-ACTIVE PRINCIPLE (ADCS) OF KSP INHIBITORS WITH ANTI-B7H3 ANTIBODIES
EA201790787A1 (en) REDUCTION OF VISCOSITY OF PHARMACEUTICAL COMPOSITIONS
CL2016002794A1 (en) Peptide vaccine comprising a mutant ras peptide and a chemotherapeutic agent
BR112017006113A2 (en) synergistic combinations of auristatin
DOP2017000307A (en) ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARATION OF THE SAME.
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
TW201613592A (en) Glucose metabolism ameliorating agent
PH12019502316A1 (en) Combination cancer immunotheraphy with pentaaza macrocyclic ring complex
ECSP18060820A (en) DERIVATIVES OF 3- (CARBOXYETHYL) -8-AMINO-2-OXO-1,3-DIAZA-SPIRO- [4.5] - DECANE
MX2017013795A (en) Therapeutic combinations of antiviral and anti-inflammatory therapies.
BR112016016932A8 (en) use of a combination of oxaliplatin (oxa), leucovorin (lv) and 5-fluorouracil (5-fu)
MX2018002681A (en) AGENT FOR ENHANCING IMMUNITY TO CANCER BY USING Allergin-1 ANTAGONIST.
UA105323U (en) Method for treating mixed nematode-cestode invasion in chickens
MX2018008196A (en) Treatment of breast cancer using a combination of a cationic liposomal formulation of taxane, a non-liposomal formulation of taxane and a further active agent.
MX2019013207A (en) Methods and compositions for treating endometriosis and endometriosis associated symptoms.
MX2018015240A (en) Compositions comprising timolol and their use in the treatment of rosacea by topical administration.
CL2016000542A1 (en) Composition comprising hydroxypropyl chitosan together with pharmaceutically acceptable excipients and / or adjuvants; useful in the treatment of onychomycosis.
BR112018009279A2 (en) oxadiazospiro compounds for the treatment of drug abuse and addiction
UA121529U (en) METHOD OF PREHABILITATION OF HANDLING IN PATIENTS WITH EXUDATIVE MEDICAL OTITIS